Addex Therapeutics (ADXN) Payables (2018 - 2026)
Addex Therapeutics (ADXN) posted Payables of $1.4 million for Q1 2026, down 5.97% sequentially from $1.5 million in Q4 2025, and up 32.89% YoY from $1.1 million in Q1 2025.
Addex Therapeutics (ADXN) Payables (2018 - 2026) Analysis & Trends
Addex Therapeutics has reported Payables for 9 years, with the latest figure at $1.4 million in Q1 2026.
- Quarterly Payables rose 32.89% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 million (up 32.89% YoY) and the FY2025 annual result came in at $1.4 million, up 59.04% from the prior year.
- Payables slipped to $1.4 million in Q1 2026 per ADXN's latest filing, from $1.5 million in the prior quarter.
- Over five years, Payables peaked at $4.2 million in Q2 2022 and troughed at $907266.7 in Q4 2024.
- A 5-year average of $2.3 million and a median of $2.0 million in 2023 frame the typical range for Payables.
- The widest YoY moves for Payables: up 64.28% in 2025, down 72.23% in 2025.
- Over 5 years, Payables stood at $3.1 million in 2022, then retreated by 13.57% to $2.7 million in 2023, then tumbled by 66.25% to $907266.7 in 2024, then soared by 64.28% to $1.5 million in 2025, then fell by 5.97% to $1.4 million in 2026.
- According to Business Quant data, Payables over the past three periods registered $1.4 million, $1.5 million, and $1.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.09 Bn | 131.23 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.66 Bn | 77.66 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.86 Bn | 59.67 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.07 Bn | 52.93 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.87 Bn | 36.77 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.45 Bn | 28.15 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 27.90 Bn | 9.51 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - | 35.57 Mn |
| 10 | Addex Therapeutics | 514.31 Mn | 514.31 Mn | - | 1.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.40 Mn |
| Dec 31, 2025 | 1.49 Mn |
| Sep 30, 2025 | 1.46 Mn |
| Jun 30, 2025 | 1.38 Mn |
| Mar 31, 2025 | 1.05 Mn |
| Dec 31, 2024 | 907,266.73 |
| Sep 30, 2024 | 1.02 Mn |
| Jun 30, 2024 | 1.03 Mn |
| Mar 31, 2024 | 3.80 Mn |
| Dec 31, 2023 | 2.69 Mn |
| Sep 30, 2023 | 1.95 Mn |
| Jun 30, 2023 | 2.80 Mn |
| Mar 31, 2023 | 3.20 Mn |
| Dec 31, 2022 | 3.11 Mn |
| Sep 30, 2022 | 3.98 Mn |
| Jun 30, 2022 | 4.21 Mn |
| Mar 31, 2022 | 3.99 Mn |
| Dec 31, 2021 | 4.17 Mn |
| Sep 30, 2021 | 3.25 Mn |
| Jun 30, 2021 | 3.76 Mn |